Display options
Cite
Hamilton DD, Cotton BA. Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency. Clin Pharmacol. 2010;2:77-82doi: 10.2147/CPAA.S6475.
Hamilton, D. D., & Cotton, B. A. (2010). Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency. Clinical pharmacology : advances and applications, 277-82. https://doi.org/10.2147/CPAA.S6475
Hamilton, David D, and Cotton, Bryan A. "Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency." Clinical pharmacology : advances and applications vol. 2 (2010): 77-82. doi: https://doi.org/10.2147/CPAA.S6475
Hamilton DD, Cotton BA. Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency. Clin Pharmacol. 2010;2:77-82. doi: 10.2147/CPAA.S6475. Epub 2010 Apr 27. PMID: 22291489; PMCID: PMC3262370.
Copy Download .nbib Format: NLM
Share it on

Clin Pharmacol. 2010;2:77-82. doi: 10.2147/CPAA.S6475. Epub 2010 Apr 27.

Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency.

Clinical pharmacology : advances and applications

David D Hamilton, Bryan A Cotton

Affiliations

  1. Department of Surgery, The University of Texas Health Science Center, Houston, TX, USA.

PMID: 22291489 PMCID: PMC3262370 DOI: 10.2147/CPAA.S6475

Abstract

Adrenocortical insufficiency occurs when there is inadequate release of cortisol from the adrenal cortex. Disturbances of the hypothalamic-pituitary-adrenal axis are common following trauma, surgical stress, and critical illness. While this is often a protective mechanism, these responses may become "uncoupled" or maladaptive resulting in an exacerbation of organ failure and higher mortality rates. In these clinical settings, the patient presents with a persistent systemic inflammation state, a hyperdynamic cardiovascular response, and vasopressor dependent shock. As such, the occurrence of adrenal insufficiency in the setting of critical illness is most appropriately termed critical illness-related corticosteroid insufficiency. In these settings, recent data suggests that these patients may benefit from a short course of low-dose steroid replacement therapy. Cosyntropin, a synthetic derivative of adrenocorticotropic hormone, is being used with increased frequency in the evaluation and diagnosis of adrenocortical insufficiency in this patient population. A random cortisol level is checked before a 250-μg injection of cosyntropin and then 30-60 minutes later. The cortisol levels and response to cosyntropin may be interpreted to identify an insufficient adrenal response. Of note, the setting of critical illness can greatly affect the cosyntropin test sensitivity on identifying adrenal insufficiency. Changes in the stress response during critical illness combined with the resuscitation and management of these patients greatly disturbs serum protein levels, especially those of albumin and transcortin. Common intensive care unit (ICU) diagnoses such as sepsis and malnutrition can increase baseline levels and blunt the cortisol response to cosyntropin stimulation, respectively. As well, numerous pharmacological agents routinely used in the ICU have been shown to interfere with cortisol levels and cosyntropin responsiveness. While steroids have a place in the ICU, specific dosing and length of administration remain inconsistent.

Keywords: ACTH; adrenal insufficiency; cosyntropin; critical illness

References

  1. N Engl J Med. 2004 Apr 15;350(16):1629-38 - PubMed
  2. Calcif Tissue Int. 1982;34(6):523-6 - PubMed
  3. World J Surg. 2003 Jun;27(6):627-31 - PubMed
  4. Clin Endocrinol (Oxf). 1994 Dec;41(6):757-61 - PubMed
  5. Biochem Pharmacol. 1981 Apr 1;30(7):727-33 - PubMed
  6. J Clin Endocrinol Metab. 1980 Jan;50(1):52-6 - PubMed
  7. JAMA. 2002 Aug 21;288(7):862-71 - PubMed
  8. Endocrinology. 1990 Jul;127(1):101-6 - PubMed
  9. Chest. 2005 Mar;127(3):1031-8 - PubMed
  10. Intensive Care Med. 2005 Mar;31(3):325-6 - PubMed
  11. Am J Med. 1995 Mar;98(3):266-71 - PubMed
  12. Lancet. 1971 Mar 27;1(7700):623-5 - PubMed
  13. Lancet. 2003 May 31;361(9372):1881-93 - PubMed
  14. Crit Care Med. 2008 Jun;36(6):1937-49 - PubMed
  15. Arch Surg. 1993 Jun;128(6):673-6 - PubMed
  16. N Engl J Med. 2008 Jan 10;358(2):111-24 - PubMed
  17. N Engl J Med. 1996 Oct 17;335(16):1206-12 - PubMed
  18. BMJ. 2004 Aug 28;329(7464):480 - PubMed
  19. JAMA. 2000 Feb 23;283(8):1038-45 - PubMed
  20. Pharmacotherapy. 2007 Nov;27(11):1512-28 - PubMed
  21. J Clin Endocrinol Metab. 1981 Jul;53(1):58-68 - PubMed
  22. Anaesthesia. 1987 Sep;42(9):929-37 - PubMed
  23. N Engl J Med. 2003 Feb 20;348(8):727-34 - PubMed
  24. J Trauma. 1987 Apr;27(4):384-92 - PubMed
  25. Anaesthesia. 2002 Apr;57(4):413 - PubMed
  26. Ann Intern Med. 2003 Aug 5;139(3):194-204 - PubMed
  27. Ann Surg. 1977 Jul;186(1):29-33 - PubMed
  28. Crit Care Clin. 2001 Jan;17(1):25-41 - PubMed
  29. Crit Care Med. 2007 Apr;35(4):1012-8 - PubMed
  30. Crit Care Med. 1999 Apr;27(4):723-32 - PubMed
  31. Ann Intern Med. 2004 Jul 6;141(1):47-56 - PubMed
  32. Intensive Care Med. 2008 Apr;34(4):714-9 - PubMed
  33. Intensive Care Med. 2000 Jan;26(1):125-7 - PubMed
  34. Arch Surg. 2008 Jan;143(1):62-7; discussion 67 - PubMed
  35. Dtsch Med Wochenschr. 1994 Apr 15;119(15):555-9 - PubMed
  36. JAMA. 2000 Jul 19;284(3):308-9 - PubMed
  37. Crit Care Med. 2005 Oct;33(10):2358-66 - PubMed
  38. Lancet. 1989 Sep 23;2(8665):704-9 - PubMed
  39. Chest. 2009 Jan;135(1):181-193 - PubMed
  40. Am J Surg. 2002 Dec;184(6):649-53; discussion 653-4 - PubMed
  41. N Engl J Med. 1972 May 25;286(21):1125-8 - PubMed
  42. Chest. 2001 Mar;119(3):889-96 - PubMed
  43. Crit Care Med. 1998 Apr;26(4):645-50 - PubMed

Publication Types